This inventor holds 2 USPTO granted patents. Top assignee: Lihpao Life Science Corp.. Active years: 2018-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2020
Title: The Innovations of Chun-Ming Tsai
Introduction
Chun-Ming Tsai is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical science, particularly in the evaluation of treatments for cancer. With a total of 2 patents, his work focuses on improving patient outcomes through innovative methodologies.
Latest Patents
Chun-Ming Tsai's latest patents include a method for evaluating the efficacy of an EGFR-TKI treatment. This invention provides a systematic approach to assess the effectiveness of the treatment by identifying the V384D mutation in patients. By recognizing this mutation, healthcare providers can estimate the efficacy of the EGFR-TKI treatment and the progression-free survival of the subject after treatment.
Career Highlights
Chun-Ming Tsai is associated with Lihpao Life Science Corporation, where he applies his expertise in developing innovative solutions for medical challenges. His work has been instrumental in advancing the understanding of targeted therapies in oncology.
Collaborations
Chun-Ming Tsai collaborates with Teh-Ying Chou, contributing to the advancement of research and development in their field. Their partnership exemplifies the importance of teamwork in driving innovation.
Conclusion
Chun-Ming Tsai's contributions to medical science through his patents and collaborations highlight his commitment to improving patient care. His innovative methods pave the way for more effective cancer treatments, showcasing the impact of dedicated inventors in the healthcare industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile